Myeloid Cells: Investigating their Role for Immunotherapy in Cancer

Project Information

MIRIC

Grant agreement ID: 101030984

DOI

10.3030/101030984

Project terminated on 23 December 2022

EC signature date 19 March 2021

Start date 1 January 2022

End date 1 March 2025

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 203 149,44

EU contribution

€ 203 149,44

Coordinated by

UNIVERSITAT BASEL
Switzerland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

TIM-3 restrains anti-tumour immunity by regulating inflammasome activation

Author(s): Karen O. Dixon,1,2,3 Marcin Tabaka,3 Markus A. Schramm,1,2,6 Sheng Xiao,1,2,7 Ruihan Tang,1,2 Danielle Dionne,3 Ana. C. Anderson,1,2,3 Orit Rozenblatt-Rosen,3,8 Aviv Regev,3,4,5,8 and Vijay K. Kuchroo1,2,3,✉
Published in: Nature, 2021, ISSN 1476-4687
Publisher: Nature
DOI: 10.1038/s41586-021-03626-9